Keyphrases
Bleomycin
100%
Pulmonary Function
100%
SiRNA Nanoparticle
100%
Interleukin-11 (IL-11)
100%
Idiopathic Pulmonary Fibrosis
100%
Nanoparticle Targeting
100%
Lung Fibrosis
100%
Nanoparticles
33%
Self-assembly
33%
Respiratory Disease
33%
Mouse Model
33%
Nanoparticle Systems
33%
Therapeutic Potential
33%
Collagen
33%
PLGA-PEG
33%
Small Interfering RNA (siRNA)
33%
Cationic Lipids
33%
RNA Therapeutics
33%
Fibroblasts
33%
Myofibroblast
33%
Diblock Copolymer
33%
Clinical Potential
33%
Transmucosal Delivery
33%
Mucus
33%
Inhalable
33%
Systemic Toxicity
33%
ACTA2
33%
Bleomycin-induced Pulmonary Fibrosis
33%
Smad2
33%
Actin alpha 2
33%
Profibrotic Cytokines
33%
Inhaled Delivery
33%
Fibrosis Development
33%
Fibroblast Differentiation
33%
ECM Deposition
33%
Driving Process
33%
Aerosol Inhalation
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Small Interfering RNA
100%
Fibrosing Alveolitis
100%
Bleomycin
100%
Lung Fibrosis
100%
Mouse Model
33%
Cytokine
33%
Fibrosis
33%
Polyethylene Glycol
33%
Copolymer
33%
Carbon 14
33%
Respiratory Tract Disease
33%
Bleomycin-Induced Pulmonary Fibrosis
33%
Interleukin 11
33%
Alpha Actin
33%